Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.

The company's bankruptcy has spotlighted the vulnerability of private consumer genetic testing data.

Me, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy to facilitate a sale, prompting many of its 15 million customers to wonder: ...

The DNA data from around 15 million people around the world is going on sale. As Nature reports, consumer-genomics company 23andMe has filed for bankruptcy — and legal permission to auction off all of ...

SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and ...

Three congressmen on the House Committee on Energy and Commerce sent a letter to the genetic testing company 23andMe on ...

23andme declared bankruptcy in late March, sparking concerns about data security for its users ... 23andMe has also been ...

Attorneys general from 27 states and the District of Columbia moved to appoint a consumer privacy ombudsman and security ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

The US Justice Department said Thursday it may review a potential sale of 23andMe users’ genetic data for potential national ...

On March 23, 2025, 23andMe, along with its affiliates, filed for voluntary Chapter 11 bankruptcy. The company’s decision to file for ...

23andMe filed for bankruptcy amid financial struggles and fallout after a data breach. Now, potential buyers and investors ...